Designed as a five-week clinical intervention, the program is accessed via an off-line, home-based tablet, making it available to users across a wider range of socio-demographic groups and geographic locations.
The benefits of TALI were evaluated in a gold standard clinical trial. This research is published in highly regarded international journals.
TALI adapts to each individual child’s game play to ensure they are constantly challenged.
Novita is Italian for Innovation – “Innovation in Healthcare”.
The vision for the company is to position itself at the forefront of innovative medical technologies with TALI as the foundation product for the future. Novita will continue to focus on commercialisation of TALI Train and the research of TALI Detect.
Novita will simultaneously seek alternative investment opportunities to capitalise on innovative medical technologies as it seeks to build a sustainable and viable business model for shareholders.
TALI Health Pty Ltd is based in Melbourne, Australia and is made up of a team of neuroscientists, software engineers, game developers and all-round talented individuals. Our vision is to be a leader in the assessment and treatment of childhood attention difficulties. We aim to assist children in reaching their full potential by providing engaging training software clinically proven to improve core cognitive performance. Under the leadership of the TALI Health board of directors, scientific advisory board and Chief Research Officer Dr Hannah Kirk, our team of experts design, develop, and evaluate training exercises that target core issues in early childhood and academic skills.
in developmental psychology
of children globally are identified as having severe attention difficulties
of Australian children start school with reduced attention capacity
is the estimated annual cost to the Australian economy